EP1804810A4 - Methodes de traitement de maladie renale mettant en oeuvre des glycosaminoglycanes - Google Patents
Methodes de traitement de maladie renale mettant en oeuvre des glycosaminoglycanesInfo
- Publication number
- EP1804810A4 EP1804810A4 EP05807269A EP05807269A EP1804810A4 EP 1804810 A4 EP1804810 A4 EP 1804810A4 EP 05807269 A EP05807269 A EP 05807269A EP 05807269 A EP05807269 A EP 05807269A EP 1804810 A4 EP1804810 A4 EP 1804810A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- glycosaminoglycans
- treatment
- methods
- kidney disease
- kidney
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61547204P | 2004-10-01 | 2004-10-01 | |
US62233204P | 2004-10-26 | 2004-10-26 | |
PCT/US2005/035790 WO2006039709A1 (fr) | 2004-10-01 | 2005-10-03 | Methodes de traitement de maladie renale mettant en oeuvre des glycosaminoglycanes |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1804810A1 EP1804810A1 (fr) | 2007-07-11 |
EP1804810A4 true EP1804810A4 (fr) | 2008-02-27 |
Family
ID=36142893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05807269A Withdrawn EP1804810A4 (fr) | 2004-10-01 | 2005-10-03 | Methodes de traitement de maladie renale mettant en oeuvre des glycosaminoglycanes |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1804810A4 (fr) |
JP (1) | JP2008515807A (fr) |
AU (1) | AU2005292202A1 (fr) |
CA (1) | CA2583079A1 (fr) |
IL (1) | IL182353A0 (fr) |
WO (1) | WO2006039709A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0613677A2 (pt) * | 2005-07-22 | 2011-01-25 | Trf Pharma Inc | método para tratar doença de célula falsiforme e sequelas da doença de célula falsiforme |
ES2352801T3 (es) | 2005-12-22 | 2011-02-23 | Kiacta Sàrl | Tratamiento de nefropatía diabética. |
JP6131258B2 (ja) * | 2011-10-11 | 2017-05-17 | ヘマフロー セラピューティクス インコーポレイテッドHemaflo Therapeutics,Inc. | 急性腎臓損傷を治療するための組成物及び溶液 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998046237A1 (fr) * | 1997-04-16 | 1998-10-22 | The United States of America, represented by The Secretary, Department of Health & Human Services | Methode de traitement de maladies vasculaires evolutives chroniques accompagnees de cicatrices |
WO2002100417A2 (fr) * | 2001-06-12 | 2002-12-19 | Keryx Biopharmaceuticals Inc. | Methodes de traitement d'une nephropathie au moyen de glycosaminoglycanes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1245907B (it) * | 1991-05-17 | 1994-10-25 | Alfa Wassermann Spa | Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica. |
IT1270846B (it) * | 1993-05-10 | 1997-05-13 | Alfa Wassermann Spa | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. |
-
2005
- 2005-10-03 JP JP2007534903A patent/JP2008515807A/ja active Pending
- 2005-10-03 WO PCT/US2005/035790 patent/WO2006039709A1/fr active Application Filing
- 2005-10-03 AU AU2005292202A patent/AU2005292202A1/en not_active Abandoned
- 2005-10-03 EP EP05807269A patent/EP1804810A4/fr not_active Withdrawn
- 2005-10-03 CA CA002583079A patent/CA2583079A1/fr not_active Abandoned
-
2007
- 2007-04-01 IL IL182353A patent/IL182353A0/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998046237A1 (fr) * | 1997-04-16 | 1998-10-22 | The United States of America, represented by The Secretary, Department of Health & Human Services | Methode de traitement de maladies vasculaires evolutives chroniques accompagnees de cicatrices |
WO2002100417A2 (fr) * | 2001-06-12 | 2002-12-19 | Keryx Biopharmaceuticals Inc. | Methodes de traitement d'une nephropathie au moyen de glycosaminoglycanes |
Non-Patent Citations (4)
Title |
---|
GRCEVSKA L ET AL: "Low-Molecular Weight Heparin Treatment in Patients with Glomerular Sclerosis", CLINICAL NEPHROLOGY, DUSTRI VERLAG, NUENCHEN-DEISENHOFEN, DE, vol. 54, no. 3, 3 November 2000 (2000-11-03), pages 14 - 17, XP002996199, ISSN: 0301-0430 * |
KRZOSSOK S ET AL: "Treatment of proteinuria with low-molecular-weight heparin after renal transplantation", TRANSPLANT INTERNATIONAL 2004 GERMANY, vol. 17, no. 8, 2004, pages 468 - 472, XP002463613, ISSN: 0934-0874 * |
LINES D R ET AL: "Focal glomerulosclerosis treated with heparin.", ARCHIVES OF DISEASE IN CHILDHOOD JUN 1989, vol. 64, no. 6, June 1989 (1989-06-01), pages 855 - 857, XP008087042, ISSN: 1468-2044 * |
See also references of WO2006039709A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU2005292202A1 (en) | 2006-04-13 |
EP1804810A1 (fr) | 2007-07-11 |
IL182353A0 (en) | 2008-04-13 |
JP2008515807A (ja) | 2008-05-15 |
WO2006039709A1 (fr) | 2006-04-13 |
CA2583079A1 (fr) | 2006-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1248630A1 (zh) | 用於組合式超聲治療的系統 | |
EP1928453A4 (fr) | Procedes et compositions permettant de prevenir et de traiter les maladies renales | |
AP2378A (en) | Sulfonamide derivatives for the treatment of diseases. | |
AP2359A (en) | Sulfonamide derivatives for the treatment of diseases. | |
ZA200700281B (en) | Dihydropteridinones for the treatment of cancer diseases | |
ZA200800452B (en) | Methods and compositions for the prevention and treatment of kidney disease | |
ZA200708819B (en) | Methods and compositions for the prevention and treatment of kidney disease | |
EP1755670A4 (fr) | Methodes pour traiter des maladies vasculaires | |
GB2430002B (en) | Well treatment | |
EP1768656A4 (fr) | Traitement de maladies oculaires | |
IL182353A0 (en) | Methods using glycosaminoglycans for the treatment of kidney disease | |
GB0400802D0 (en) | Compounds for the treatment of disease | |
GB0426196D0 (en) | Methods of treatment | |
GB0424085D0 (en) | Well treatment | |
GB0413635D0 (en) | Ultrasonic treatment | |
ZA200606780B (en) | Compounds for the treatment of diseases | |
HU0401379D0 (en) | Process for the preparation of risperidon | |
GB0428291D0 (en) | Methods of regenerating NOx-Absorbent | |
GB0516753D0 (en) | Molecular methods for the treatment of disease | |
GB0415352D0 (en) | Compounds for the treatment of disease | |
IL177531A0 (en) | Compounds for the treatment of diseases | |
GB0425073D0 (en) | Compounds for the treatment of diseases | |
GB0420867D0 (en) | Compounds for the treatment of diseases | |
AP2006003743A0 (en) | Compounds useful for the treatment of diseases | |
GB0425064D0 (en) | Compounds useful for the treatment of diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070425 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 13/12 20060101ALI20080117BHEP Ipc: A61K 31/726 20060101ALI20080117BHEP Ipc: A61K 31/70 20060101AFI20060828BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20080125 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090505 |